STRATA Skin Sciences Announces Upcoming KOL Call Hosted by Ladenburg Thalmann

Rhea-AI Summary

STRATA Skin Sciences (NASDAQ: SSKN) announced the upcoming Key Opinion Leader (KOL) Call hosted by Ladenburg Thalmann on August 16, 2022, at 11:00 AM ET. Dr. Benjamin Lockshin will discuss the growing markets for psoriasis and vitiligo, emphasizing the role of STRATA’s XTRAC Excimer Laser in treatment outcomes. The call aims to highlight the company's innovative technologies, which include the XTRAC and Pharos excimer lasers and TheraClear X Acne Therapy System. Registration details for the live call are available on STRATA's website.

Positive

• The upcoming KOL Call may increase awareness and interest in STRATA's XTRAC technology among investors and healthcare professionals.
• Emphasis on the growing psoriasis and vitiligo markets could indicate potential for increased demand for STRATA's products.

Negative

• None.

Call to Highlight the Growing Psoriasis and Vitiligo Markets and the Importance of STRATA’s XTRAC Technology Within the Treatment Landscape

HORSHAM, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the Company’s XTRAC Excimer Laser will be highlighted in an upcoming Key Opinion Leader (KOL) Call hosted by Ladenburg Thalmann.

The KOL will be hosted by Jeff Cohen, Managing Director at Ladenburg Thalmann on Tuesday August 16^th at 11:00 am ET / 8:00 am PT. Dr. Benjamin Lockshin, MD FAAD, Director of the Clinical Trials Center at DermAssociates will showcase vitiligo and psoriasis and the impact STRATA’s XTRAC excimer laser has on treatment and outcomes.

A link to register for the live call will be available on the STRATA Skin Sciences website at www.strataskinsciences.com under the investor relations section.

About STRATA Skin Sciences, Inc.

STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing and marketing innovative products for the in-office treatment of various dermatologic conditions such as psoriasis, vitiligo, and acne. Its products include the XTRAC^® and Pharos^® excimer lasers, VTRAC^® lamp systems, and now the TheraClear^®X Acne Therapy System.

STRATA is proud to offer these exciting technologies in the U.S. through its unique Partnership Program. STRATA’s popular partnership approach includes a fee per treatment cost structure versus an equipment purchase, installation and use of the device, on-site training for practice personnel, service and maintenance of the equipment, dedicated account and customer service associates, and co-op advertising support to help raise awareness and promote the program within the practice.

Investor Contact
Jack Droogan
(203) 585-4140
ir@strataskin.com

FAQ

What is STRATA Skin Sciences' stock symbol?

STRATA Skin Sciences trades under the stock symbol SSKN.

When is the KOL Call hosted by Ladenburg Thalmann?

The KOL Call is scheduled for August 16, 2022, at 11:00 AM ET.

Who will present during the KOL Call?

Dr. Benjamin Lockshin, MD FAAD, will present during the KOL Call.

What is the main focus of the KOL Call?

The KOL Call will focus on the increasing psoriasis and vitiligo markets and STRATA’s XTRAC Excimer Laser's impact on treatment outcomes.

Where can I find registration details for the KOL Call?

Registration details for the KOL Call can be found on STRATA Skin Sciences' website under the investor relations section.